FIELD: chemical-pharmaceutical industry. SUBSTANCE: therapeutic combination involves calcium in elemental form and at least one vitamin D as an associated active component. It has also at least one dry and moisture binding agent (synergetic amount) with at least one vehicle, at least one binding agent and at least one binding agent being at least one of indicated vehicles and indicated binding agents is a sweetening agent. Ratio of calcium in elemental form to vitamin D expressed as mg of elemental calcium per international unit (IU) of vitamin D is mainly 1-1.5 but, preferably, is 1.2-1.3. Invention provides maintenance of absolute and relative doses of calcium and vitamin D and correct treatment carrying out. EFFECT: enhanced effectiveness of combination. 16 cl
